EyePoint, Inc. — SC 13G Filings
16 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by EyePoint, Inc. (EYPT), sorted by most recent first. Each row links to the full filing on EdgarLookup. EyePoint, Inc. has filed 16 SC 13G documents with the SEC since 2008. To view all SEC filings by EyePoint, Inc., see the full filings list.
All
10-K
10-K/A
10-KT
10-Q
10-Q/A
144
144/A
20-F
20FR12G
3
3/A
4
4/A
424B3
424B5
5
6-K
6-K/A
8-K
8-K/A
8-K12G3
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
F-3
F-3/A
F-6
F-6 POS
FWP
NT 10-K
NT 10-Q
NT 20-F
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0002012383-24-003467 | Nov 8, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-253167 | Nov 7, 2024 | — |
| SC 13G | — | 0002012383-24-001254 | Oct 22, 2024 | — |
| SC 13G | EYEPOINT PHARMACEUTICALS, INC. | 0000902664-24-003112 | Apr 30, 2024 | — |
| SC 13G | — | 0000080255-24-000689 | Feb 14, 2024 | — |
| SC 13G | EYEPOINT PHARMACEUTICALS, INC. | 0001104659-21-105143 | Aug 13, 2021 | — |
| SC 13G | — | 0000919574-21-004691 | Jul 26, 2021 | — |
| SC 13G | EYEPOINT PHARMACEUTICALS, INC. | 0000902664-21-001296 | Feb 12, 2021 | — |
| SC 13G | SC 13G | 0001019056-17-000364 | Apr 7, 2017 | — |
| SC 13G | SC 13G | 0001019056-17-000198 | Feb 14, 2017 | — |
| SC 13G | SC 13G | 0001144204-14-017375 | Mar 24, 2014 | — |
| SC 13G | SC 13G | 0001193125-14-054960 | Feb 14, 2014 | — |
| SC 13G | — | 0001144204-10-019348 | Apr 9, 2010 | — |
| SC 13G | — | 0001144204-09-024445 | May 6, 2009 | — |
| SC 13G | ORBIS INVESTMENT MANAGEMENT (AUSTRALIA) PTY LIMITED | 0001085146-07-001132 | Nov 29, 2007 | — |
| SC 13G | BENEFICIAL OWNERSHIP OF 5% OR MORE | 0001104659-06-010161 | Feb 16, 2006 | — |